These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8527275)

  • 1. Marked enhancement by rifampicin and lack of effect of isoniazid on the elimination of quinine in man.
    Wanwimolruk S; Kang W; Coville PF; Viriyayudhakorn S; Thitiarchakul S
    Br J Clin Pharmacol; 1995 Jul; 40(1):87-91. PubMed ID: 8527275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cigarette smoking enhances the elimination of quinine.
    Wanwimolruk S; Wong SM; Coville PF; Viriyayudhakorn S; Thitiarchakul S
    Br J Clin Pharmacol; 1993 Dec; 36(6):610-4. PubMed ID: 12959282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dose size on the pharmacokinetics of orally administered quinine.
    Sowunmi A; Salako LA
    Eur J Clin Pharmacol; 1996; 49(5):383-6. PubMed ID: 8866633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral quinine pharmacokinetics and dietary salt intake.
    Newton P; Simpson A; Wanwimolruk S; Maliakal P; Villegas L; Kuypers D; White NJ
    Eur J Clin Pharmacol; 2001 May; 57(2):111-3. PubMed ID: 11417441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is quinine a suitable probe to assess the hepatic drug-metabolizing enzyme CYP3A4?
    Wanwimolruk S; Paine MF; Pusek SN; Watkins PB
    Br J Clin Pharmacol; 2002 Dec; 54(6):643-51. PubMed ID: 12492613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a concomitant single oral dose of rifampicin on the pharmacokinetics of pravastatin in a two-phase, randomized, single-blind, placebo-controlled, crossover study in healthy Chinese male subjects.
    Deng S; Chen XP; Cao D; Yin T; Dai ZY; Luo J; Tang L; Li YJ
    Clin Ther; 2009 Jun; 31(6):1256-63. PubMed ID: 19695392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of quinine in man: identification of a major metabolite, and effects of smoking and rifampicin pretreatment.
    Wanwimolruk S; Wong SM; Zhang H; Coville PF; Walker RJ
    J Pharm Pharmacol; 1995 Nov; 47(11):957-63. PubMed ID: 8708992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of quinine in chronic liver disease.
    Auprayoon P; Sukontason K; Na-Bangchang K; Banmairuroi V; Molunto P; Karbwang J
    Br J Clin Pharmacol; 1995 Nov; 40(5):494-7. PubMed ID: 8703656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of concurrent administration of nevirapine on the disposition of quinine in healthy volunteers.
    Soyinka JO; Onyeji CO; Omoruyi SI; Owolabi AR; Sarma PV; Cook JM
    J Pharm Pharmacol; 2009 Apr; 61(4):439-43. PubMed ID: 19298689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of examination in healthy volunteers of rifampicin and isoniazid bioavailability from Polish two-drug combination capsules of rifamazid used for tuberculosis treatment].
    Zofia Z; Niemirowska-Mikulska H; Augustynowicz-Kopeć E; Stambrowska A
    Pneumonol Alergol Pol; 1998; 66(3-4):198-206. PubMed ID: 9857665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of quinine in patients with chronic renal failure.
    Rimchala P; Karbwang J; Sukontason K; Banmairuroi V; Molunto P; Na-Bangchang K
    Eur J Clin Pharmacol; 1996; 49(6):497-501. PubMed ID: 8706776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of quinine in plasma after a single oral and intramuscular dose in healthy adult Africans.
    Sowunmi A
    East Afr Med J; 1996 Feb; 73(2):111-4. PubMed ID: 8756050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of repeated administration of rifampicin and isoniazid on vitamin D metabolism in mice.
    Sheng L; Xue Y; He X; Zhu Y; Li H; Wu Y; Dang R; Tang M; Jiang P
    Steroids; 2015 Dec; 104():203-7. PubMed ID: 26476181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral bioavailability of rifampicin, isoniazid, ethambutol, and pyrazinamide in a 4-drug fixed-dose combination compared with the separate formulations in healthy Chinese male volunteers.
    Xu J; Jin H; Zhu H; Zheng M; Wang B; Liu C; Chen M; Zhou L; Zhao W; Fu L; Lu Y
    Clin Ther; 2013 Feb; 35(2):161-8. PubMed ID: 23410999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioequivalence study of rifampicin in fixed-dose combination of rifampicin and isoniazid vs. separate formulations.
    Panchagnula R; Singh I; Kaur KJ; Kaul CL
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):625-8. PubMed ID: 10669909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of rifampicin and pyrazinamide on isoniazid pharmacokinetics in rats.
    Baldan HM; De Rosa HJ; Brunetti IL; Ximenes VF; Machado RG
    Biopharm Drug Dispos; 2007 Nov; 28(8):409-13. PubMed ID: 17828712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels.
    Agrawal S; Singh I; Kaur KJ; Bhade SR; Kaul CL; Panchagnula R
    Int J Pharm; 2004 May; 276(1-2):41-9. PubMed ID: 15113612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative bioavailability of rifampicin, isoniazid and ethambutol from a combination tablet vs. concomitant administration of a capsule containing rifampicin and a tablet containing isoniazid and ethambutol.
    Schall R; Müller FO; Duursema L; Groenewoud G; Hundt HK; Middle MV; Mogilnicka EM; Swart KJ
    Arzneimittelforschung; 1995 Nov; 45(11):1236-9. PubMed ID: 8929247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and elimination of quinine in healthy volunteers.
    Mirghani RA; Hellgren U; Bertilsson L; Gustafsson LL; Ericsson O
    Eur J Clin Pharmacol; 2003 Sep; 59(5-6):423-7. PubMed ID: 12920491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The combined effect of isoniazid and rifampicin on the activities of CYP4501A2 and CYP4503A4 in primary hepatocytes from healthy human adults].
    Liu ZW; Hu ZH; Cai YY
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Nov; 28(11):785-8. PubMed ID: 16324277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.